AIM: Noninvasive ventilation (NIV) is used for patients with chronic obstructive pulmonary disease (COPD) and chronic hypercapnia. However, evidence for clinical efficacy and optimal management of therapy is limited. METHOD: We Continue Reading →
Overed-Sayer C, Miranda E, Dunmore R, et al Thorax Published Online First: 24 July 2020. AIM: Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disease which presents a grave prognosis for diagnosed patients. Continue Reading →
Rhodes C J, Otero-Nuñez P, Wharton J et al Am J Respir CCMed 202 (4) 586–594, Aug 15 2020 AIM: Idiopathic and heritable pulmonary arterial hypertension (PAH) are rare but Continue Reading →
Raghu G, Remy-Jardin M, Ryerson C J et al Am J Respir Crit C M 202 3 p 36-69, Aug 1, 2020 AIM: This guideline addresses the diagnosis of hypersensitivity pneumonitis Continue Reading →
Brunwasser S, Snyder B M, Driscoll A J et al Lancet Respir Med 2020 (8) 795–806 AIM: It is unclear whether lower respiratory tract infections (LRTIs) with respiratory syncytial virus Continue Reading →
Buendía-Roldán I, Santiago-Ruiz L, Pérez-Rubio G et al Eur Respir J 2020 56 1901380 AIM: Hypersensitivity pneumonitis is an immune-mediated disease triggered by exposure to organic particles in susceptible individuals. Continue Reading →
Aogain M, Lau K, Cai Z et al Am J Respir Crit Care Med Vol 202 (3) 433–447, Aug 1 2020 AIM: Long-term antibiotic use for managing chronic respiratory disease Continue Reading →
Yu, J., Zhou, D., Yang, X. et al. Nature Commun 11, 3660 (2020) AIM: High expression or aberrant activation of epidermal growth factor receptor (EGFR) is related to tumor progression and therapy Continue Reading →
Jacob J, Aksman L, Mogulkoc N, et al. Thorax 2020;75:648-654. AIM: Patients with idiopathic pulmonary fibrosis (IPF) receiving antifibrotic medication and patients with non-IPF fibrosing lung disease often demonstrate rates of annualised forced vital capacity (FVC) decline Continue Reading →
Chakrabarti B, Lewis-Burke N, Pearson M et al ERJ Open Res 2020; 6: 00362-2019 AIM: To describe implementation of a computer-guided consultation (CGC) clinical decision support system in the assessment of suspected obstructive Continue Reading →
Camille Taillé, Pascal Chanez, Gilles Devouassoux et al European Respiratory Journal 2020 55: 1902345; DOI: 10.1183/13993003.02345-2019 AIM: Mepolizumab was available in France as part of an early access programme for Continue Reading →
Karl Peter Sylvester, Nigel Clayton, Ian Cliff et al. BMJ Open Respiratory Research 2020;7:e000575. 5th July 2020 doi: 10.1136/bmjresp-2020-000575 The ARTP have provided within this document the most up-to-date and Continue Reading →
Kevin K. Brown, Fernando J. Martinez, Simon L.F. Walsh et al. Eur Respir J 2020 55:2000085; published ahead of print 2020 doi:10.1183/13993003.00085-2020 AIM: Idiopathic pulmonary fibrosis (IPF) is, by definition, Continue Reading →
Zaroff, J.G., Cheetham T.C, Palmetto N et al. JAMA Netw Open. 2020;3(6):e208199. doi:10.1001/jamanetworkopen.2020.8199 AIM: Azithromycin, a macrolide, is one of the most commonly prescribed antibiotics in the US, with an Continue Reading →
Bruno L. Ferreyro, Federico Angriman, Laveena Munshi et al. JAMA. 2020;324(1):57–67. doi:10.1001/jama.2020.9524 AIM: To compare the association of non-invasive oxygenation strategies with mortality and endotracheal intubation in adults with acute hypoxemic Continue Reading →